EUVIMEDEUVIMED entdecken
Open Access

Calbindin 2 as a Novel Biomarker and Therapeutic Target for Abdominal Aortic Aneurysm: Integrative Analysis of Human Proteomes and Genetics

Yulin Bao, Jiayi Chen, Xudong Han, Ye He, Tongtong Yang, Xinying Shi, Jiawen Chen, Lingfeng Gu, Sibo Wang iD, Liping Xie iD, Hao Wang iD, Liansheng Wang iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.039195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Yulin Bao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology The First Affiliated Hospital with Nanjing Medical University Nanjing Jiangsu China. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, Proteome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Abdominal aortic aneurysm (AAA) is a clinical life‐threatening issue. No pharmacological treatments are currently approved for the prevention and treatment of AAA. Therefore, identifying novel biomarkers and therapeutic targets is crucial for improving AAA management and outcomes.

Methods

To identify plasma proteins with potential causal effects on AAA, we integrated genetic evidence from proteome‐wide Mendelian randomization, genetic correlation, and colocalization analysis. The role of identified proteins in AAA was further explored through the phenome‐wide association study and mediation analysis. Multiomics data analysis, including bulk RNA sequencing, single‐cell/single‐nucleus RNA sequencing, and spatial transcriptomics, was employed to characterize the expression patterns of these proteins. Experimental validation was performed using an AAA model in apolipoprotein E‐deficient mice infused with angiotensin II. Druggability analysis was conducted to identify drug candidates, which were tested in preclinical mouse models.

Results

CALB2 (calbindin 2) was identified as having a causal effect on AAA and may influence the progression of AAA through the regulation of lipid metabolism. Multiomics analysis revealed that CALB2 is predominantly expressed in the mesothelial cells of adipose tissues. Inhibition of CALB2 in an AAA mouse model alleviated AAA progression. Druggability analysis identified lenalidomide and genistein as potential therapeutic candidates, and experiments confirmed their efficacy in preventing AAA development.

Conclusions

This study identifies CALB2 as being associated with an increased risk of AAA and suggests that i might be a novel biomarker and therapeutic molecule for AAA management. Lenalidomide and genistein hold promising potential as treatments for patients with AAA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, AbdominalProteomeAnimalsHumansMiceDisease Models, AnimalBiomarkersMaleMice, Knockout, ApoEMice, Inbred C57BLGenome-Wide Association Study

Stichwörter der Autor:innen

Mendelian randomizationabdominal aortic aneurysmcalbindin 2plasma proteinproteogenomic

Substanzen

BiomarkersProteome

Autor:innen und Institutionen

  • Department of Cardiology The First Affiliated Hospital with Nanjing Medical University Nanjing Jiangsu China.
  • Key Laboratory of Cardiovascular and Cerebrovascular Medicine, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine Nanjing…

ORCID-Profile: Sibo Wang, Liping Xie, Hao Wang, Liansheng Wang

Zitieren

APA

Bao, Y., Chen, J., Han, X., He, Y., Yang, T., Shi, X., Chen, J., Gu, L., Wang, S., Xie, L., Wang, H., & Wang, L. (2025). Calbindin 2 as a Novel Biomarker and Therapeutic Target for Abdominal Aortic Aneurysm: Integrative Analysis of Human Proteomes and Genetics. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.039195

Vancouver

Bao Y, Chen J, Han X, He Y, Yang T, Shi X, et al. Calbindin 2 as a Novel Biomarker and Therapeutic Target for Abdominal Aortic Aneurysm: Integrative Analysis of Human Proteomes and Genetics. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.039195

BibTeX
@article{Bao2025,
  author = {Bao, Yulin and Chen, Jiayi and Han, Xudong and He, Ye and Yang, Tongtong and Shi, Xinying and Chen, Jiawen and Gu, Lingfeng and Wang, Sibo and Xie, Liping and Wang, Hao and Wang, Liansheng},
  title = {Calbindin 2 as a Novel Biomarker and Therapeutic Target for Abdominal Aortic Aneurysm: Integrative Analysis of Human Proteomes and Genetics},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.039195}
}
Kostenlos starten →